|
Market Closed -
Nasdaq
21:00:00 10/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 34.08 USD | -0.29% |
|
-2.49% | -4.05% |
| 09-02 | Cogent Biosciences Enters Commercial Supply Agreement With Hovione FarmaCiencia | MT |
| 08-31 | Cogent Biosciences Insider Sold Shares Worth $1,689,493, According to a Recent SEC Filing | MT |
| Market Cap | 5.93B 5.1B 4.81B 4.39B 8.2B 567B 8.27B 57.33B 22.07B 288B 22.28B 21.79B 914B | P/E 2026 * |
-15.2x | P/E 2027 * | -33x |
|---|---|---|---|---|---|
| Enterprise Value | 5.8B 4.99B 4.71B 4.29B 8.02B 555B 8.09B 56.08B 21.58B 281B 21.79B 21.31B 894B | EV / Sales 2026 * |
969x | EV / Sales 2027 * | 19.4x |
| Free-Float |
99.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| COGT | Delayed | |
CBOE
| COGT | Real-time |
Last Transcript : Cogent Biosciences, Inc.
| 1 day | -0.29% | ||
| 1 week | -2.49% | ||
| Current month | -2.63% | ||
| 1 month | -17.94% | ||
| 3 months | +8.60% | ||
| 6 months | -7.09% | ||
| Current year | -4.05% |
| 1 week | 33.07 |  | 35.75 |
| 1 month | 33.07 | | 40.85 |
| Current year | 30.87 | | 43.39 |
| 1 year | 11.6 | | 43.73 |
| 3 years | 3.67 | | 43.73 |
| 5 years | 3.67 | | 43.73 |
| 10 years | 3.67 | | 43.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Robbins
CEO | Chief Executive Officer | 50 | 22/10/2020 |
John Green
DFI | Director of Finance/CFO | 45 | 31/05/2018 |
John Robinson
CTO | Chief Tech/Sci/R&D Officer | 52 | 05/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Karen Ferrante
BRD | Director/Board Member | 68 | 31/01/2018 |
Arlene Morris
BRD | Director/Board Member | 74 | 25/07/2019 |
Matthew Ros
BRD | Director/Board Member | 59 | 25/07/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/08/26 | Exercice | Director | 136,530 | 0.0787% | ||
| 01/07/26 | Free | Director | 627 | 0.0004% | ||
| 09/06/26 | Free | Director | 17,901 | 0.0105% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | -2.49% | +167.29% | +179.12% | 5.93B | |
| -0.25% | -0.96% | +45.25% | +102.76% | 68.52B | |
| -1.09% | -4.97% | +31.10% | +76.56% | 62.88B | |
| -1.18% | +0.47% | -12.78% | +380.30% | 28.13B | |
| -2.74% | -3.53% | +26.13% | +13.50% | 25.56B | |
| -1.76% | -6.30% | -4.55% | -18.27% | 24.65B | |
| -2.39% | -4.23% | +18.42% | -20.95% | 19.81B | |
| -1.86% | +1.15% | +205.44% | +353.89% | 17.69B | |
| -1.37% | -3.77% | -9.38% | +528.34% | 14.66B | |
| -1.54% | -2.88% | +52.33% | +161.16% | 14.45B | |
| Average | -1.45% | -1.31% | +51.92% | +175.64% | 28.23B | |
| Weighted average by Cap. | -1.26% | -1.40% | +38.48% | +139.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.99M 5.15M 4.86M 4.43M 8.28M 573M 8.35M 57.87M 22.27M 290M 22.49M 22M 922M | 295M 254M 239M 218M 407M 28.19B 411M 2.85B 1.1B 14.3B 1.11B 1.08B 45.41B |
| Net income | -399M -343M -324M -295M -551M -38.14B -556M -3.86B -1.48B -19.35B -1.5B -1.47B -61.45B | -199M -172M -162M -147M -276M -19.07B -278M -1.93B -742M -9.67B -749M -733M -30.73B |
| Net Debt | -130M -111M -105M -95.84M -179M -12.4B -181M -1.25B -482M -6.29B -487M -476M -19.97B | -206M -177M -167M -152M -285M -19.7B -287M -1.99B -767M -9.99B -774M -757M -31.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | US$34.08 | -0.29% | 2,264,524 |
| 09/09/26 | US$34.18 | -3.12% | 1,587,526 |
| 08/09/26 | US$35.28 | +1.50% | 2,244,424 |
| 04/09/26 | US$34.76 | -0.54% | 784,080 |
| 03/09/26 | US$34.95 | +1.10% | 1,268,646 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COGT Stock
Select your edition
All financial news and data tailored to specific country editions
